Jiří Beran

4PUBLICATIONS
0CO-AUTHORS
Nanotoxicology, health and safetyCardiology (incl. cardiovascular diseases)Aged care nursingPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 27, 2021
Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course.

Jiří Beran, Marián Špajdel, Jiří Slíva

|Sep 28, 2021
Correction: Beran et al. Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic. Pathogens 2020, 9, 1055.

Jirí Beran, Marian Špajdel, Věra Katzerová

|Dec 19, 2020
Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic.

Jiří Beran, Marian Špajdel, Věra Katzerová

|Nov 09, 2016
Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study.

Jiří Beran, Eva Šalapová, Marian Špajdel

Pageof 1

Frequent Collaborators